Bringing clinical trials to patients with the decentralized model

Since, COVID-19, which has had a huge impact on global clinical trials, sponsors, CROs, sites, and patients have pivoted to adapt to a more home- or community-based approach. Learn why bringing a trial to a patient’s home – with the help of home healthcare support, telemedicine and sensors, direct-to-patient drug shipments, and more –helps to minimize the barriers to recruitment and retention.


Open PDF

Return to Insights Center

Related Insights

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Video

The FDAs Race and Ethnic Diversity Plan Guidance: How prepared is your organization?

Feb 1, 2023

Podcast

Decentrally Speaking | Episode 3: Integrating the Patient Voice into Decentralized Trials

Jul 28, 2022

Article

Australia: Infrastructure and Innovations for Clinical Trials

Aug 28, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Blog

Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression

Apr 23, 2024

Article

Decentralized clinical trials - A more patient-centric approach

May 10, 2021

Blog

Decentralized Trials: Considerations for Building a New Patient-Centric Model

May 13, 2021

Blog

Including patients in DCT design

Sep 13, 2022

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Blog

A patient-centric approach to managing clinical trial complexity

Jul 13, 2021

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023